Literature DB >> 458195

Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus.

G J Jakab, G A Warr, M E Knight.   

Abstract

Pulmonary and systemic defenses against hematogenous challenge with 32P-labeled Staphylococcus aureus were measured 10 min, 8 hr, and 24 hr after intravenous injection of the bacteria in a mouse model of influenza virus pneumonia. Infection with influenza A virus did not alter bactericidal defenses in the liver and spleen, but pulmonary bactericidal activity measured 24 hr after infection was suppressed in virus-infected animals; 20% +/- 3% of the initially injected, viable bacteria were recovered from lungs of pneumonitic mice after 24 hr as compared with 9% +/- 1% from lungs of the uninfected mice. These data demonstrate that pulmonary infection with influenza virus does not alter antibacterial defenses of the liver and spleen but does suppress bactericidal activity in the lung.

Entities:  

Mesh:

Year:  1979        PMID: 458195     DOI: 10.1093/infdis/140.1.105

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

2.  Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.

Authors:  Anupa Kudva; Erich V Scheller; Keven M Robinson; Chris R Crowe; Sun Mi Choi; Samantha R Slight; Shabaana A Khader; Patricia J Dubin; Richard I Enelow; Jay K Kolls; John F Alcorn
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

Review 3.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

4.  Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.

Authors:  A Opgenorth; K Graham; N Nation; D Strayer; G McFadden
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Histopathological changes in the lungs of influenza-infected mice superinfected with Staphylococcus aureus.

Authors:  I D Gardner; T M Kung
Journal:  Br J Exp Pathol       Date:  1980-08

6.  Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity.

Authors:  J S Abramson; J C Lewis; D S Lyles; K A Heller; E L Mills; D A Bass
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.

Authors:  J P Wong; L L Stadnyk; E G Saravolac
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

8.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

Authors:  G S Giebink; I K Berzins; S C Marker; G Schiffman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model.

Authors:  Scott D Kobayashi; Randall J Olsen; Rachel A LaCasse; David Safronetz; Madiha Ashraf; Adeline R Porter; Kevin R Braughton; Friederike Feldmann; Dawn R Clifton; John C Kash; John R Bailey; Donald J Gardner; Michael Otto; Douglas L Brining; Barry N Kreiswirth; Jeffrey K Taubenberger; Michael J Parnell; Heinz Feldmann; James M Musser; Frank R DeLeo
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

10.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.